Mitra Biotech Stock

personalized cancer treatment

Sign up today and learn more about Mitra Biotech Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Sands Capital Ventures


Woburn MA, US

Total Funding


About Mitra Biotech Stock

Mitra is an innovative biotechnology company dedicated to discover tools to segregate patients for existing and developing anti-cancer treatments. Mitra is addressing significant challenges in personalized cancer medicine with dedicated scientists educated and trained in world famous institutes. Mitra’s discoveries to detect and manage cancer have practical applications and will be moved from the bench to bedside.


Funding History

April 2010$2.2M
October 2013$4.9M
August 2016$27.4M
July 2018$40.0M


Chief Commercial Officer

Parker Cassidy

Co-Founder & CSO

Pradip Majumder

Co-Founder, President & CEO

Mallik Sundaram


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: